1. Home
  2. AVNS vs CAPR Comparison

AVNS vs CAPR Comparison

Compare AVNS & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avanos Medical Inc.

AVNS

Avanos Medical Inc.

HOLD

Current Price

$24.80

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$31.59

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNS
CAPR
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
AVNS
CAPR
Price
$24.80
$31.59
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$44.63
AVG Volume (30 Days)
2.0M
1.0M
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
81.59
N/A
EPS
0.11
N/A
Revenue
$701,200,000.00
N/A
Revenue This Year
$3.28
N/A
Revenue Next Year
$4.23
$3.31
P/E Ratio
$225.41
N/A
Revenue Growth
1.95
N/A
52 Week Low
$9.30
$4.30
52 Week High
$24.81
$40.37

Technical Indicators

Market Signals
Indicator
AVNS
CAPR
Relative Strength Index (RSI) 90.70 46.63
Support Level $12.75 $26.06
Resistance Level N/A $36.66
Average True Range (ATR) 0.07 2.11
MACD -0.33 -0.46
Stochastic Oscillator 64.52 41.25

Price Performance

Historical Comparison
AVNS
CAPR

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: